Drees P, Decking J, Ghezel-Ahmadi V, Delank K-S, Wilhelm B, Eckardt A
Orthopädische Klinik und Poliklinik der Johannes-Gutenberg-Universität, Mainz.
Z Rheumatol. 2005 Oct;64(7):488-98. doi: 10.1007/s00393-005-0705-9.
Increasing bone mineral density (BMD) has been found in several studies in patients with osteoarthritis. Therefore, many clinicians deny the simultaneous occurrence of osteoporosis (OP) and osteoarthritis (OA). Because of our clinical impression however, we suggested that we have to consider a common occurrence. Furthermore, the value of markers of bone turn over with a view to early diagnosis of OP and or as an assessment for bone metabolism in OA is still a matter debate and their clinical use has not been clearly defined in the management of the individual patient.
The BMD of the lumbar spine and the proximal femur of 119 OA patients (83 postmenopausal female patients aged 50-83 and 35 male patients aged 36-86 years) who subsequently required hip or knee replacements, but were otherwise healthy, were measured by dual energy X-ray absorption (DXA), Hologic QDR-2000. We also measured biochemical markers of bone turn over, i. e., CICP, ICTP, DPD, PTH, estrogen, testosterone, bAP, hydroxy vitamin D and the normal blood count.
There was a high occurrence of a low BMD among the patients. A total of 28.9% of women were affected by OP and 52.9% by osteopoenie. This reflects the normal distribution of OP in the female population. Of the male patients 20% had OP and 38.8% osteopoenie. This is astonishing high. Age proved to be a significant factor in the degree of BMD. An association between disuse osteoporosis and degree of BMD in the OA affected joint could not be proven. The use of the biochemical markers for an earlier diagnosis or to assess bone metabolism in OP and OA was not possible.
We can not support the hypotheses that OA prevents OP. Moreover, the occurrence of OP in our study reflected the incidence of OP in the average female and the astonishingly high incidence in the male population; however does not mean that the two conditions are mutually exclusive. We did not find that the biochemical markers of bone turn over could deliver additional information with respect to bone metabolism and an earlier diagnosis of OP.
多项研究发现骨关节炎患者骨矿物质密度(BMD)有所增加。因此,许多临床医生否认骨质疏松症(OP)和骨关节炎(OA)会同时发生。然而,基于我们的临床印象,我们认为必须考虑两者同时存在的情况。此外,骨转换标志物对于OP早期诊断以及作为OA骨代谢评估指标的价值仍存在争议,其在个体患者管理中的临床应用尚未明确界定。
对119例OA患者(83例年龄在50 - 83岁的绝经后女性患者和35例年龄在36 - 86岁的男性患者)进行腰椎和股骨近端BMD测量,这些患者随后需要进行髋关节或膝关节置换,但其他方面健康,采用双能X线吸收法(DXA),Hologic QDR - 2000进行测量。我们还测量了骨转换的生化标志物,即骨钙素(CICP)、Ⅰ型胶原交联羧基末端肽(ICTP)、脱氧吡啶啉(DPD)、甲状旁腺激素(PTH)、雌激素、睾酮、骨碱性磷酸酶(bAP)、羟基维生素D以及血常规。
患者中低BMD发生率较高。共有28.9%的女性患有OP,52.9%患有骨质减少。这反映了OP在女性人群中的正常分布。男性患者中20%患有OP,38.8%患有骨质减少。这一比例高得惊人。年龄被证明是BMD程度的一个重要因素。未证实OA受累关节的废用性骨质疏松与BMD程度之间存在关联。无法使用生化标志物进行OP和OA的早期诊断或评估骨代谢。
我们不支持OA可预防OP这一假说。此外,我们研究中OP的发生率反映了普通女性人群中OP的发病率以及男性人群中惊人的高发病率;然而这并不意味着这两种情况相互排斥。我们未发现骨转换生化标志物能提供有关骨代谢及OP早期诊断的额外信息。